HER2+ Metastatic Breast Cancer

Elisa Agostinetto, MD, Institut Jules Bordet

Videos

Promising New Therapies for HER2-Low Breast Cancer

02/28/2022

In part 2 of this series, Dr Agostinetto, Institut Jules Bordet, discusses several effective, promising agents in HER2-low breast cancer treatment.

In part 2 of this series, Dr...

02/28/2022

Oncology

Videos

Dr Harbeck Talks Pertuzumab Plus Trastuzumab in HR-/HER2+ Early Breast Cancer

06/07/2021

Nadia Harbeck, MD, PhD, discusses results from the ADAPT-HR-/HER2+ trial on early breast cancer.

Nadia Harbeck, MD,...

06/07/2021

Oncology

Videos

Dr Chavez Mac Gregor Discusses the Treatment of Metastatic HER2+ Breast Cancer

04/19/2021

Mariana Chavez Mac Gregor, MD, MSC, University of Texas, MD Anderson Cancer Center, highlights her approach to treating patients with metastatic HER2 + breast cancer.

Mariana Chavez Mac Gregor, MD,...

04/19/2021

Oncology

Videos

Dr George Highlights Advancements in HER2+ Breast Cancer Therapy

04/11/2021

Mridula George, MD, discusses the addition of HER2 targeted agents within the last 2 decades that have been studied in the metastatic, adjuvant, and the neoadjuvant setting.

Mridula George, MD, discusses...

04/11/2021

Oncology